Ernexa Therapeutics (ERNAW) Current Taxes (2010 - 2026)
Ernexa Therapeutics (ERNAW) reported Current Taxes of $4000.0 for Q1 2026, down 63.64% on a YoY basis from $11000.0 in Q1 2025, and up 33.33% quarter-over-quarter from $3000.0 in Q4 2025.
Ernexa Therapeutics (ERNAW) Current Taxes (2010 - 2026) Analysis & Trends
Ernexa Therapeutics has reported Current Taxes for 15 years, with the latest figure at $4000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes fell 63.64% year-over-year to $4000.0; the trailing twelve-month figure through Mar 2026 stood at $4000.0 (down 63.64% YoY), and the FY2025 full-year result was $3000.0, changed 0.0% from the prior year.
- Current Taxes for Q1 2026 stood at $4000.0, up from $3000.0 in the prior quarter.
- The five-year high for Current Taxes was $18000.0 in Q3 2024, with the low at $2000.0 in Q3 2023.
- Historically, Current Taxes has averaged $7615.4 across 4 years, with a median of $7000.0 in 2023.
- Annual changes were most pronounced in 2024 — Current Taxes surged 800.0% — and 2026, when it tumbled 63.64%.
- Ernexa Therapeutics' Current Taxes stood at $2000.0 in 2023, then jumped by 50.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025, then jumped by 33.33% to $4000.0 in 2026.
- The last three Current Taxes figures came in at $4000.0 (Q1 2026), $3000.0 (Q4 2025), and $17000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Sep 30, 2020 | 14,000.00 |
| Mar 31, 2020 | 19,000.00 |
| Dec 31, 2019 | 3,000.00 |
| Sep 30, 2019 | 71,000.00 |
| Jun 30, 2019 | 67,000.00 |
| Mar 31, 2019 | 77,000.00 |